RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/29541409http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/29541409http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/29541409http://www.w3.org/2000/01/rdf-schema#comment"Androgen deprivation therapy (ADT) is palliative and prostate cancer (CaP) recurs as lethal castration-recurrent/resistant CaP (CRPC). One mechanism that provides CaP resistance to ADT is primary backdoor androgen metabolism, which uses up to four 3α-oxidoreductases to convert 5α-androstane-3α,17β-diol (DIOL) to dihydrotestosterone (DHT). The goal was to determine whether inhibition of 3α-oxidoreductase activity decreased conversion of DIOL to DHT. Protein sequence analysis showed that the four 3α-oxidoreductases have identical catalytic amino acid residues. Mass spectrometry data showed combined treatment using catalytically inactive 3α-oxidoreductase mutants and the 5α-reductase inhibitor, dutasteride, decreased DHT levels in CaP cells better than dutasteride alone. Combined blockade of frontdoor and backdoor pathways of DHT synthesis provides a therapeutic strategy to inhibit CRPC development and growth."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.org/dc/terms/identifier"doi:10.18632/oncotarget.24107"xsd:string
http://purl.uniprot.org/citations/29541409http://purl.org/dc/terms/identifier"doi:10.18632/oncotarget.24107"xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Li Y."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Wu Y."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Wu Y."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Wilson E.M."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Wilson E.M."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Mohler J.L."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Mohler J.L."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Watt D.S."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Watt D.S."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Attwood K.M."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Attwood K.M."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Azabdaftari G."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Azabdaftari G."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Fiandalo M.V."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Fiandalo M.V."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Mantione K.M."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Mantione K.M."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Pop E.A."xsd:string
http://purl.uniprot.org/citations/29541409http://purl.uniprot.org/core/author"Pop E.A."xsd:string